{"id":372721,"title":"Clinical Trial Application - Amendments (CTA-As) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T17:39:07.772000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/application-amendments.html","snippet":"Clinical Trial Application - Amendments (CTA-As) CTA-A s are applications in which a sponsor proposes information to support changes to a previously authorized application [ C.05.008 ]. Where a sponsor wishes to make changes to a CTA under review, the sponsor should withdraw the…","rawSnapshotUrl":"/api/snapshots/raw/372721","browseUrl":"https://replay.healtharchive.ca/job-6/20260411173907/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/application-amendments.html#ha_snapshot=372721","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}